AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Trimegabose 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Trimegabose 2mg/500mg/0.2mg Tablet

Diabexe Trio 2 mg/500 mg/0.2 mg tablets are classified as antidiabetic medications. This combination therapy manages type 2 diabetes in adults by regulating blood glucose. Diabexe Trio should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify its symptoms – sweating, dizziness, headache, and tremors – and know how to treat it. Regular meals and readily available glucose sources (like sugary snacks or juice) are essential. Alcohol consumption should be minimized due to its potential to lower blood sugar. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Its suitability during pregnancy or breastfeeding requires prior medical consultation. Regular blood glucose monitoring is necessary, and your doctor might order blood tests to track blood cell counts and liver function.

Primary Ingredients of Trimegabose 2mg/500mg/0.2mg Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Trimegabose 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Trimegabose 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Trimegabose 2 mg/500 mg/0.2 mg tablets on an empty stomach.

Common Side effects of Trimegabose 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Trimegabose 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Trimegabose 2 mg/500 mg/0.2 mg Tablet on an empty stomach.

How Trimegabose 2mg/500mg/0.2mg Tablet works:

Each Trimegabose tablet (2 mg/500 mg/0.2 mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Trimegabose 2 mg/500 mg/0.2 mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Trimegabose 2 mg/500 mg/0.2 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Trimegabose 2 mg/500 mg/0.2 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Trimegabose 2 mg/500 mg/0.2 mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, its use is discouraged in individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Trimegabose 2 mg/500 mg/0.2 mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advisable. Initiation with a reduced dose is typical for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Trimegabose 2mg/500mg/0.2mg Tablet :

Should you forget to take your Trimegabose 2 mg/500 mg/0.2 mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Trimegabose 2mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Trimegabose 2mg/500mg/0.2mg Tablet

Trimegabose 2 mg/500 mg/0.2 mg tablets contain glimepiride, metformin, and voglibose, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances glycemic control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases postprandial blood glucose. This formulation is unsuitable for type 1 diabetes.
Taking Trimegabose 2 mg/500 mg/0.2 mg tablets may result in common adverse reactions including low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, headache, skin eruptions, and upper respiratory infections.
Patients with hypersensitivity to Trimegabose 2 mg/500 mg/0.2 mg Tablet constituents or inactive ingredients should not take this medication. Its administration is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel disorders, colonic ulcers, and pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Trimegabose 2 mg/500 mg/0.2 mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Trimegabose 2 mg/500 mg/0.2 mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Store as directed on the product packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Trimegabose 2mg/500mg/0.2...
90
MRP 110
18% off